| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |